DAVIS, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (Nasdaq: MBII) (MBI), a leading provider of effective and environmentally responsible pest management and plant health ...

Davis-based Marrone Bio Innovations announced Monday that its founder, Dr. Pamela Marrone, would soon retire as chief executive officer. Marrone will stay with the biotech company until a new CEO is ...

DAVIS, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (“MBI” or the “Company”) (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for ...

Pam Marrone became the CEO of Marrone Bio Innovations, Inc. (NASDAQ:MBII) in 2006. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we'll consider ...

Marrone Bio Innovations, Inc. (MBII) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.03 per share a year ago. These figures are ...

Marrone Bio Innovations, Inc. (MBI) MBII, a leading global provider of bio-based pest management products for the agricultural and water treatment markets, announced today the issuance of a patent by ...

DAVIS, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced ...

Please see the risks that are described from time to time in Marrone Bio Innovations’ and Evogene’s Securities and Exchange Commission reports (including but not limited to Marrone Bio Innovations’ ...

The company raised $66 million at a post-IPO valuation of $228 million in 2013 and faced a rough first few years of life as a public company. The travails were punctuated by results that disappointed ...